GI medication
1. Ç︮ÄÚ¹ÚÅÍ Á¦±ÕÄ¡·á
DAPURA[lansoprazole] cap 30mg 1t bid 7days
Amoxapen [amoxicillin]cap 250mg 4cap bid 7days
Klaricid[ XL[clarithromycin] tab 500mg 1T bid 7days
2. Chronic gastritis , Gastric ulcer scar , ¼ÓÀÌ ´õºÎ·è, ¼ÒȺҷ®, º¯ºñ
Esmezol 40mg qd
Panbutine 1T tid
Mosazal tab(mosapride) 5mg 1T tid
Mucosta 100 mg tid
Sylcon 625mg 1T tid
3. Crohn¡¯s disease
¼ö¼úÈÄ short bowel syndromeÀ¸·Î öºÐºÎÁ·ÀÌ
»ý±â¸é
Venoferum 20mg 2A À» N/S 100cc¿¡ ¹Í½ºÇÏ¿© ¸ÅÀÏ ÁÖ»ç
º¸Åë
¼ºÀÎÀÇ °æ¿ì 1ÁÖ 2-3ȸ,
1ȸ 1-2¾ÚÇÃ(ö·Î¼ 100-200mg)À» Çì¸ð±Û·Îºó ¼öÄ¡¿¡ µû¶ó Åõ¿©ÇÑ´Ù.
(ÃÖ´ë 1ȸ Åõ¿©·®): ¾Æ·¡Ç¥ÀÇ ¾ÚÇÃÀº
5cc (100mg) ¾ÚÇñâÁØ
60g/L = 6.0mg/dL
Á¡ÀûÁֻ縦
ÀÌ¿ë : 1A(100mg)À» N/S 100cc¿¡ ¹Í½º. ´õ ÁøÇÏ¸é ¾ÈµÈ´Ù
Á÷Á¢
Á¤¸Æ ÁÖ»ç : 5ºÐ¿¡ °ÉÃļ ÁÖ»ç , 1ȸ 2A±îÁö Åõ¿©°¡´É
4. Epigastric
soreness
À§³»½Ã°æ»ó Chr.gastritis with IM
ó¹æ :
Stogar(lafutidine)
Lamina-G
5. Gastric SMT
ó¹æ : ¾à¾ÈÁÖ°í 3°³¿ùµÚ EGD f/uÇÏÀÚ
6. GERD
ó¹æ : ³îÅØÁ¤(illaprazole 10mg) 3T bid 7days ó¹æÇßÀ½. f/uÇØ¶óÇß°ÚÁö?
7. À§Á¡¸·º¸È£Á¦(±Ë¾ç¾à)
1) sucralfate (¾Æ·ç»ç·ç¹Î, ¼öÅ©·¹ÀÌÆ®)
»ïÃâ¹°¿¡ Æ÷ÇÔµÈ ´Ü¹éÁú°ú °áÇÕÇÏ¿©, ²öÀûÀÌ´Â paste °°Àº ¹°ÁúÀ» Çü¼ºÇÏ¿©
protective coatingÀ» Çü¼ºÇÏ¿©, gastric liningÀÌ À§»ê, Æé½Å, bile salt·Î ºÎÅÍ º¸È£
±×¿ÜÀÛ¿ë : stimulates angiogenesis and the formation of granulation tissue, possibly due to growth factor binding
suppress H. pylori
inhibit acid secretion
ºÎÀÛ¿ë : µå¹°´Ù(constipation 2~3%)(ÆÄ¿ö³»°ú)
H2 blockerº¸´Ù Ä¡À¯ ¼Óµµ, ÅëÁõ°¨¼Ò ºü¸£´Ù
Dietary Considerations : Take
with water on an empty stomach(uptodate19.3)
Treatment of duodenal ulcer: Oral(uptodate19.3)
Initial treatment:
1 g 4 times/day, 1 hour before meals or food and at bedtime for 4-8 weeks
alternatively 2 g twice daily; treatment is recommended for 4-8 weeks in
adults
Maintenance/prophylaxis of duodenal ulcer: 1 g twice daily
2) Bismuth(µ¥³î, ±Ô¿Ã)
Bismuth subsalicylate exhibits both antisecretory(¼³»ç¾à) and antimicrobial action. This agent may provide some anti-inflammatory action as well. The salicylate moiety provides antisecretory effect and the bismuth exhibits antimicrobial directly against bacterial and viral gastrointestinal pathogens
ulcer¿¡ ºÙ¾î¼ ³´°ÔÇϰí, PGºÐºñÇØ¼ mucus,
bicarbonateºÐºñÇÏ°Ô Çϰí, H.pylori Á×À̰í, ¿°Áõµµ °¡¶ó¾ÉÈ÷°í, ÁÁÀº¾àÀÓ..
ºÎÀÛ¿ë : °ËÀºº¯, º¯ºñ, Àå±â »ç¿ë½Ã
neurotoxicity
3) Prostaglandin (E1) analogue : Misoprostol(ÆÄ¿ö³»°ú)
Ä¡·áÈ¿°ú : mucosal defense & repair Çâ»ó(ÆÄ¿ö³»°ú)
Á¡¾×°ú Áßź»ê
»ý¼º ÃËÁø, Á¡¸· Ç÷·ù Áõ°¡(ÃֽŰ¡Á¤ÀÇÇÐ)
Active ulcer Ä¡·á¿¡´Â ´Ù¸¥ ¾àÁ¦º¸´Ù ´ú È¿°úÀû(ÆÄ¿ö³»°ú)
NSAIDS induced ulcer ¿¹¹æ¿¡¸¸ ¾²ÀδÙ(ÆÄ¿ö³»°ú)
ºÎÀÛ¿ë : ¼³»ç, ÀÚ±ÃÃâÇ÷/¼öÃà, À¯»ê(ÆÄ¿ö³»°ú)
4) Rebapimide(À§Å°Çǵð¾Æ)
ÇÁ·Î½ºÅ¸±Û¶õµò »ýÇÕ¼º ÃËÁø(À§Å°)
¹æ¾î Áõ°(À§Å°)
¹æ¾î Áõ°Á¦ Áß À¯ÀÏÇÏ°Ô Ç×»êÈÈ¿°úÀÖ¾î -> Ç︮ÄÚ¹ÚÅÍ¿¡ ÀÇÇÑ ¿°Áõ Á¦°Å(À§Å°)
8. ¼ÒȺҷ®¾à (Àå¿îµ¿ ÃËÁøÁ¦)
1) cisapride(5HT4 agonist)
°æ±¸¿ë À§Àå°ü
¿îµ¿ ÃËÁøÁ¦·Î¼, ÀÛ¿ë±âÀüÀº ÁÖ·Î ±ÙÃþ°£ ½Å°æÃÑ(myenteric
plexus)¿¡¼ acetylcholineÀÇ ºÐºñ¸¦ Áõ°¡½Ã۴µ¥ ÀÖ´Ù°í ¿©°ÜÁø´Ù(drug info)
¡¤ À§½Äµµ¿ª·ùÁúȯÀÇ ¾ß°£ Áõ»ó Ä¡·á (drug info)
¡¤ À§Àå°ü ¸¶ºñ (drug info)
¡¤ ºÒÀÀ¼º º¯ºñ (drug info)
¡¤ ºñ±Ë¾ç¼º ¼ÒȺҷ®(drug info)
½ÉÀåºÎÀÛ¿ëÀ¸·Î ¿äÁòÀº ·¹º¸ÇÁ¶óÀ̵带 ¾´´Ù?(ÀÎÅÍ³Ý , ±¹½ÃÃ¥)
QT prolongation
2) Levosulpiride ·¹º¸ÇÁ¶óÀ̵åDopamine 2 receptor antagonist CNS¿¡¼´Â D2 pre-synaptic autoreceptor¿¡¸¸ ¼±ÅÃÀûÀ¸·Î ÀÛ¿ë
À§Àå°ü ¿îµ¿ Á¶ÀýÁ¦ (GI tract regulators)
º¹ºÎ ÆØ¸¸°¨, »óº¹ºÎ ºÒÄè°¨, ¼Ó¾²¸², Æ®¸², ÇൿÀå¾Ö, ´ç´¢º´¼º
À帶ºñ, ¼ÒȺҷ®, À§½Äµµ ¿ª·ùÁúȯ, °ú¹Î¼º ´ëÀåÁõÈıº, ÆíµÎÅë, Ç×¾ÏÁ¦·Î
ÀÎÇÑ ±¸Åä, ¸¸¼º±¸Åä, ÀϹÝÀûÀÎ ±¸Åä, ¼ö¼ú ÈÄ ±¸Åä
¡¤
±âŸ : ½Ã¾ßÈ帲, ¸ñÀÌ ½°, È«Á¶, µÎµå·¯±â
3) Itopride(ÀÌÅäÇÁ¸®µå)
Acetylcholine esterase ÀúÇØ È¿°ú¿Í Dopamine D2 receptor¸¦ ±æÇ×ÇÏ´Â È¿°ú¸¦ °¡Áø´Ù
±â´É¼º ¼ÒȺҷ®À¸·Î ÀÎÇÑ ¼Òȱâ Áõ»ó(º¹ºÎÆØ¸¸°¨, »óº¹ºÎÅë, ½Ä¿åºÎÁø, ÈäÅë, ¿À½É, ±¸Åä)¿¡ »ç¿ëµÈ´Ù.
4) Domperidone
BBB´Â Åë°ú¾ÈÇÑ´Ù
ºÎÀÛ¿ë : ÇÁ·Î¶ôƾÁõ°¡·Î À¯ÁóºÐºñ
5) TCA , SSRI ¼ÒȺҷ®¾àÀ¸·Î½á
TCA : IBS¿¡¼ IBS Áõ»ó (transit
time ´À·ÁÁü , ¼³»ç, º¹Åë ) (ÇØ¸®½¼18ÆÇ) (ÃֽŰ¡Á¤ÀÇÇÐ)º¹ÅëÀ» ÁÙÀδÙ(±¹½ÃÃ¥)
SSRI : IBS-C¿¡¼ ÁÖ·Î ÀÛ¿ë(transit
time »¡¶óÁü , ÁÖ·Î º¯ºñ¿¡) ¾ÆÁ÷ ¿¬±¸
´õ ÇÊ¿ä(ÇØ¸®½¼18ÆÇ)
9. Á¦»êÁ¦(Antacids)
°ú°Å¿¡´Â
¼Òȱ˾ç¾àÀ¸·Î ¾²¿´À¸³ª, ÃÖ±Ù ´ÜÁö Áõ»ó¿ÏÈ¾à ¿ëµµ(±¹½ÃÃ¥)
º¸Åë ½ÄÈÄ 1½Ã°£¿¡ º¹¿ëÀÌ È¿°úÀû(±¹½ÃÃ¥)
Á¾·ù : ÀÎ»ê ¾Ë·ç¹Ì´½, ¼ö»êÈ ¾Ë·ç¹Ì´½, ±Ô»ê ¾Ë·ç¹Ì´½
»êÈ ¸¶±×³×½·, ź»ê ¸¶±×³×½·, ¼ö»êÈ ¸¶±×³×½·
ź»ê Ä®½·
±âÀü : ÁßÈÀ̿ܿ¡µµ ´Ù¸¥ ±âÀüÀ¸·Î gastric mucosa¸¦ º¸È£ÇÑ´Ù.
°¡¼³ : »êȾ˷ç¹Ì´½Àº growth factor¿¡ °áÇÕÇØ¼ ulcer¿¡ growth factor¸¦ Àü´ÞÇÑ´Ù.
Á¦»êÁ¦´Â injured mucosa¿¡ angiogenesis¸¦ À¯µµÇÑ´Ù
Á¦»êÁ¦´Â ´ãÁó°ú
°áÇÕÇÏ¿© peptic activity¸¦ ¾ïÁ¦ÇÑ´Ù.
Á߱ݼÓÀº H.pylori¸¦ ¹Ú¸êÇÏÁö´Â ¸øÇÏÁö¸¸, ¾ïÁ¦ÇÏ´Â °ÍÀ¸·Î Àß ¾Ë·ÁÁ®
ÀÖ´Ù.
ÀÌ °¡¼³Áß¿¡¼ ¾î¶²°ÍÀÌ
À§±Ë¾çÀÇ È¸º¹¿¡ µµ¿òÀ» ÁÖ´ÂÁö´Â È®½ÇÇÏÁö ¾Ê´Ù.
ºÎÀÛ¿ë
: ¸¶±×³×½· ÇÔÀ¯ : ¼³»ç, hypermagnesemia(½ÅºÎÀü¿¡¼¸¸ Áß¿ä)
sodium , volume
overload
calciumÀÇ
´Ù·®°ú Èí¼ö¼º ¾ËÄ®¸® : ¿¹¸¦ µé¸é calcium carbonate
-> hypercalcemia, alkalosis, renal impairment, milk alkali syndrome
¾Ë·ç¹Ì´½ : ¾Ë·ç¹Ì´½ toxicity : sucralfate´Â ¾Ë·ç¹Ì´½Æ÷ÇÔµÊ(Ä¡·á¿ë·®À¸·Î º¸Åë 0.8g Á¤µµÀ̰í Á¦»êÁ¦¿Í ºñ½ÁÇÑ ¼öÁØÀ¸·Î Èí¼ö)
ÇÏ·ç 120mmolÀÇ
¾Ë·ç¹Ì´½ Á¦»êÁ¦ ¸¦ 4ÁÖ°£ ¸Ô¾úÀ» °æ¿ì Ç÷Àå ¾Ë·ç¹Ì´½ levelÀÌ
»ó½ÂÇÑ´Ù.
½Å±â´É ÀúÇÏ, ½Å°æµ¶¼º, ºóÇ÷
½Å±â´ÉÀúÇÏ¿¡¼ sucralfate¿Í ¾Ë·ç¹Ì´½°è¿ Á¦»êÁ¦ , citrate ±â°¡ ºÙÀº
°ÍÀ» °°ÀÌ ¾²Áö¸¶¶ó.
Citrate
°è¿ÀÌ ¾Ë·ç¹Ì´½ Èí¼ö¸¦ ¸Å¿ì
Áõ°¡½ÃÅ´
Aluminum hydroxide´Â ÀÎÀÇ Èí¼ö¸¦ °¨¼Ò½ÃÅ´ , sucralfateµµ ÀÎÀÇ Èí¼ö¸¦ ¹æÇØ, °°ÀÌ ¾²Áö ¸»°Í
10. »êºÐºñ
¾ïÁ¦Á¦(±¹½ÃÃ¥)
1) H2 ¼ö¿ëü ±æÇ×Á¦
´ë»çÁö¿¬ : P450°ú °áÇÕÇØ¼ »ý±è(±¹½ÃÃ¥) , warfarin, theophyllin, phenytionµî(±¹½ÃÃ¥)
Cimetidine, ranitidine ¸¸ ±×·¸´Ù(±¹½ÃÃ¥)
Famotidine, nizatidine, roxatidineÀº ±×·¸Áö ¾Ê´Ù(±¹½ÃÃ¥)
2) PPI
°øº¹ ¾ÆÄ§ ½ÄÀü(±¹½ÃÃ¥)
11. Áö»çÁ¦
1)bismuth subsalicylate (ÆÄ¿ö³»°ú ½ÅÆÇ)
ÀåºÐºñ °¨¼Ò
±Ý±â : ¸é¿ªÀúÇÏÀÚ, ½Å±â´ÉÀúÇÏÀÚ
1) Loperamide(opioid °è¿) or diphenoxylate(ÆÄ¿ö³»°ú ½ÅÆÇ)
Àå¿îµ¿ °¨¼Ò, ÀåºÐºñ °¨¼Ò
°¨¿°¼º ¼³»ç¿¡¼´Â ±Ý±â
not infrequently, a high dose of loperamide may cause cramping(ÇØ¸®½¼ 18ÆÇ)
2) KTB(kaolin, tannalbin, Bismuth subnitrate), aluminum hydroxide (ÆÄ¿ö³»°ú ½ÅÆÇ)
4)5HT4 antagonist ¼¼Æ®·Ð
¿ëµµ : n/v
Áö»çÁ¦·Îµµ ¾²ÀÓ
5) Fiber stool bulking agent
º¸Åë º¯ºñ¾àÀÌÁö¸¸
IBS¿¡¼ ¼³»ç¿¡¼ bowel transit timeÀ» ´À¸®°Ô ÇÏ¿© µµ¿òÀÌ µÈ´Ù(ÇØ¸®½¼ 18ÆÇ)